Re JLSP and Innovation Australia – Trial to test drug’s safety was a core R&D activity
The AAT has found that an Australian-based company in an international pharmaceutical research group conducted a core R&D activity when it ran a clinical trial to determine the safety and efficacy of a client’s drug. Innovation Australia refused make an advance finding that the taxpayer’s clinical trial was a core R&D activity after finding that…

